Prenatal exposure to phthalates linked to decreased mental and motor development

These endocrine-disrupting chemicals, which are widely present in the environment, linked to increased behavioral problems at age 3 and may cause changes in the developing brain

 

New York, NY, USA (September 6, 2011) – A newly published study by researchers at Columbia University’s Mailman School of Public Health heightens concerns over the potential health effects on children of a group of ubiquitous chemicals known as phthalates. Phthalates are a class of chemicals that are known to disrupt the endocrine system, and are widely used in consumer products ranging from plastic toys, to household building materials, to shampoos.

 

Recent studies of school-age children have provided preliminary links between prenatal exposure to phthalates and developmental problems. The study is the first to examine prenatal phthalate exposure and the prevalence of mental, motor and behavioral problems in children who are in the preschool years. The paper, published online today in Environmental Health Perspectives, adds to rising concerns about the risks associated with exposures to phthalates during pregnancy.

 

The study followed the children of 319 non-smoking inner-city women who gave birth between 1999 and 2006. Researchers, led by Robin M. Whyatt, DrPH, deputy director of the Columbia Center for Children’s Environmental Health, measured metabolites of four phthalates in maternal urine as markers of prenatal exposure. The phthalates were: di-2-ethylhexyl phthalate, di-isobutyl phthalate, di-n-butyl phthalate and butylbenzyl phthalate. The study evaluated associations between prenatal exposures to these phthalates and child mental, motor and behavioral development at age 3 years.

 

The scientists used the Bayley Scales of Infant Development II, a well validated developmental test, to assess the mental and motor development of the children. Behavioral problems were measured by asking mothers to complete the widely used 99-item Child Behavior Checklist (for ages 1½-5 years). Overall, researchers found that higher prenatal exposures to two of the phthalates significantly increased the odds of motor delay, an indication of potential future problems with fine and gross motor coordination. Among girls, one of the phthalates was associated with significant decreases in mental development. Prenatal exposures to three of the phthalates were also significantly associated with behavior problems including emotionally reactive behavior, anxiety/depression, somatic complaints and withdrawn behavior. These effects differed somewhat by child sex but were statistically significant among both boys and girls.

 

"Our results suggest that prenatal exposure to these phthalates adversely affects child mental, motor and behavioral development during the preschool years," said Dr. Whyatt, who is also professor of clinical Environmental Health Sciences. "The results add to a growing public health concern about the widespread use of phthalates in consumer products."

 

The actual mechanisms by which phthalates may affect the developing brain are still being explored. Dr. Whyatt points out that phthalates are endocrine disrupters—substances that affect hormone systems in the body. Evidence suggests that they impact the function of the thyroid gland. They also lower production of testosterone, which plays a critical role in the developing brain. "More work is needed to understand the biological effects of these commonplace substances," noted Dr. Whyatt.

 

"The results are concerning since increasing exposures from the lowest 25% to the highest 25% among the women in our study was associated with a doubling or tripling in the odds of motor and/or behavioral problems in the children," explained Pam Factor-Litvak, PhD, the senior epidemiologist on the study. "However, the number of children with clinical disorders was small," stated Dr. Factor-Litvak. The authors point out that the phthalate exposures among the women in the study varied widely reflecting the range of exposures found in the U.S. population.

 

 

The study was conducted in collaboration with Dr. Antonia Calafat from the Centers for Disease Control and Prevention, who measured the phthalate metabolites in the maternal prenatal urine. Other members of the Columbia research team included Dr. Xinhua Liu, Dr. Virginia A. Rauh, Allan C. Just, Lori Hoepner, Diurka Diaz, James Quinn, Dr. Jennifer Adibi, and Dr. Frederica P. Perera.

The work was supported by a grant from the National Institute of Environmental Health Sciences.

 

 

About Columbia University’s Mailman School of Public Health

 

Founded in 1922 as one of the first three public health academies in the nation, Columbia University’s Mailman School of Public Health pursues an agenda of research, education, and service to address the critical and complex public health issues affecting New Yorkers, the nation and the world. The Mailman School is the third largest recipient of NIH grants among schools of public health. Its over 300 multi-disciplinary faculty members work in more than 100 countries around the world, addressing such issues as preventing infectious and chronic diseases, environmental health, maternal and child health, health policy, climate change & health, and public health preparedness. It is a leader in public health education with over 1,000 graduate students from more than 40 nations pursuing a variety of master’s and doctoral degree programs. The Mailman School is also home to numerous world-renowned research centers including the International Center for AIDS Care and Treatment Programs (ICAP), the National Center for Disaster Preparedness, and the Center for Infection and Immunity. For more information, please visit www.mailman.columbia.edu

 

 

About the Columbia Center for Children’s Environmental Health

 

The Columbia Center for Children’s Environmental Health (The Center) conducts community-based research in the United States and overseas to study the health effects of prenatal and early postnatal exposures to common urban pollutants, with the aim of preventing environmentally related conditions in children. We apply the results of our research to interventions that reduce exposure to toxic pollutants; a community education campaign to increase environmental health awareness among local residents, parents, health professionals and educators; and to informing public interest groups, elected officials, and other policymakers who can shape policies to improve the environmental health status of low-income communities. The Center’s overall mission is to improve prevention, clinical treatment, and engage community members to work effectively with each other and with elected officials to improve their neighborhood’s environmental health.

 

 


Columbia University’s Mailman School of Public Health, 06.09.2011 (tB)

MEDICAL NEWS

Inadequate sequencing of SARS-CoV-2 variants impedes global response to COVID-19
New meta-analysis finds cannabis may be linked to development of…
New guidance on how to diagnosis and manage osteoporosis in…
Starting the day off with chocolate could have unexpected benefits
Better mental health supports for nurses needed, study finds

SCHMERZ PAINCARE

Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…
Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern

DIABETES

Bundestag berät über DMP Adipositas: DDG begrüßt dies als Teil…
Mit der Smartwatch Insulinbildung steuern
Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…
Minimalinvasive Geräte warnen ungenügend vor Unterzuckerung
Typ-1-Diabetes und Hashimoto-Thyreoiditis treten häufig gemeinsam auf

ERNÄHRUNG

Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren

ONKOLOGIE

Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver
Positive Ergebnisse beim fortgeschrittenen Prostatakarzinom: Phase-III-Studie zur Radioligandentherapie mit 177Lu-PSMA-617
Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!
Deutsch-dänisches Interreg-Projekt: Grenzübergreifende Fortbildungskurse in der onkologischen Pflege
Sotorasib: Neues Medikament macht Lungenkrebs-Patienten Hoffnung

MULTIPLE SKLEROSE

NMOSD-Erkrankungen: Zulassung von Satralizumab zur Behandlung von Jugendlichen und Erwachsenen
Verzögerte Verfügbarkeit von Ofatumumab (Kesimpta®)
Neuer Biomarker bei Multipler Sklerose ermöglicht frühe Risikoeinschätzung und gezielte…
Multiple Sklerose beginnt oft lange vor der Diagnose
Goldstandard für Versorgung bei Multipler Sklerose

PARKINSON

Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung